Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $24.2B | -- | -- | $2.11 | -- |
| 10/23/2025 | Q3 | $22B | $22B | $2.41 | $2.57 | -$0.16 |
| 07/23/2025 | Q2 | $21B | $21.1B | $2.84 | $2.68 | $0.16 |
| 04/24/2025 | Q1 | $20.6B | $20.9B | $2.58 | $2.48 | $0.10 |
| 01/29/2025 | Q4 | $21.4B | $21.9B | $2.57 | $2.38 | $0.19 |
| 10/23/2024 | Q3 | $20B | $20.2B | $2.61 | $2.45 | $0.17 |
| 07/31/2024 | Q2 | $19.6B | $19.8B | $2.49 | $2.29 | $0.20 |
| 04/25/2024 | Q1 | $19.8B | $19.6B | $2.00 | $1.92 | $0.08 |
| 01/25/2024 | Q4 | $19.7B | $20.5B | $1.67 | $1.96 | -$0.29 |
| 10/25/2023 | Q3 | $19.4B | $19.3B | $1.82 | $1.89 | -$0.07 |
| 07/27/2023 | Q2 | -- | $19.2B | $1.86 | -- | -- |
| 04/27/2023 | Q1 | -- | $19.6B | $1.58 | -- | -- |
| 02/01/2023 | Q4 | -- | $20.3B | $1.18 | -- | -- |
| 10/27/2022 | Q3 | -- | $19.5B | $0.40 | -- | -- |
| 07/27/2022 | Q2 | -- | $19.7B | -$0.09 | -- | -- |
| 04/27/2022 | Q1 | -- | $20.1B | $0.57 | -- | -- |
| 02/02/2022 | Q4 | -- | $20.8B | $0.34 | -- | -- |
| 11/02/2021 | Q3 | -- | $19.6B | $0.55 | -- | -- |
| 07/29/2021 | Q2 | -- | $20B | $0.78 | -- | -- |
| 05/04/2021 | Q1 | -- | $19.8B | $0.74 | -- | -- |
| 02/04/2021 | Q4 | -- | $20.3B | $0.60 | -- | -- |
| 11/05/2020 | Q3 | -- | $19.3B | $1.00 | -- | -- |
| 08/06/2020 | Q2 | -- | $17.7B | $0.09 | -- | -- |
| 05/06/2020 | Q1 | -- | $11.1B | $1.10 | -- | -- |
| 02/06/2020 | Q4 | -- | $11.9B | $0.87 | -- | -- |
| 10/28/2019 | Q3 | -- | $11.1B | $1.01 | -- | -- |
| 07/25/2019 | Q2 | -- | $11B | $1.09 | -- | -- |
| 04/25/2019 | Q1 | -- | $11.1B | $1.06 | -- | -- |
| 02/07/2019 | Q4 | -- | $11.4B | $0.75 | -- | -- |
| 10/30/2018 | Q3 | -- | $10.8B | $0.93 | -- | -- |
| 08/01/2018 | Q2 | -- | $10.6B | $0.92 | -- | -- |
| 04/30/2018 | Q1 | -- | $10.5B | $0.78 | -- | -- |
| 02/08/2018 | Q4 | -- | $10.8B | $3.10 | -- | -- |
| 10/23/2017 | Q3 | -- | $10B | $0.63 | -- | -- |
| 07/19/2017 | Q2 | -- | $10.2B | $0.67 | -- | -- |
| 04/24/2017 | Q1 | -- | $9.6B | $0.80 | -- | -- |
| 02/14/2017 | Q4 | -- | $10.2B | $0.43 | -- | -- |
| 10/24/2016 | Q3 | -- | $9.3B | $0.42 | -- | -- |
| 07/27/2016 | Q2 | -- | $9.3B | $0.25 | -- | -- |
| 04/26/2016 | Q1 | -- | $8.7B | $0.56 | -- | -- |
| 02/17/2016 | Q4 | -- | -- | -- | -- | -- |
T-Mobile US, Inc. reported $22B worth of top line sales in its most recent quarter.
T-Mobile US, Inc. announced earnings per share of $2.41 which represents a miss of analyst forecast a $2.57 per share.
T-Mobile US, Inc. reported $10.8B that represents $9.61 per share over the last quarter.
T-Mobile US, Inc.'s earnings are forecast to grow from $9.66 per share to $9.57 per share next year representing an increase of 8.33%.
T-Mobile US, Inc.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.